37.75
Precedente Chiudi:
$38.26
Aprire:
$37.6
Volume 24 ore:
647.37K
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.74B
Reddito:
-
Utile/perdita netta:
$-146.66M
Rapporto P/E:
-13.71
EPS:
-2.7541
Flusso di cassa netto:
$-133.21M
1 W Prestazione:
-7.52%
1M Prestazione:
-14.71%
6M Prestazione:
-8.73%
1 anno Prestazione:
-17.49%
Apogee Therapeutics Inc Stock (APGE) Company Profile
Nome
Apogee Therapeutics Inc
Settore
Industria
Telefono
650-394-5230
Indirizzo
221 CRESCENT ST., WALTHAM
Confronta APGE con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
APGE
Apogee Therapeutics Inc
|
37.75 | 2.23B | 0 | -146.66M | -133.21M | -2.7541 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-07 | Reiterato | BTIG Research | Buy |
2025-03-13 | Iniziato | Citigroup | Buy |
2024-11-25 | Iniziato | Canaccord Genuity | Buy |
2024-05-10 | Iniziato | BofA Securities | Buy |
2023-12-20 | Iniziato | BTIG Research | Buy |
2023-08-08 | Iniziato | Guggenheim | Buy |
2023-08-08 | Iniziato | Jefferies | Buy |
2023-08-08 | Iniziato | Stifel | Buy |
2023-08-08 | Iniziato | TD Cowen | Outperform |
2023-08-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Apogee Therapeutics Inc Borsa (APGE) Ultime notizie
How many analysts rate Apogee Therapeutics Inc. as a “Buy”Maximize your returns with expert insights - jammulinksnews.com
Is Apogee Therapeutics Inc. a good long term investmentInvest smarter with expert stock picks - jammulinksnews.com
What is the risk reward ratio of investing in Apogee Therapeutics Inc. stockAchieve consistent profits with proven methods - jammulinksnews.com
Should I hold or sell Apogee Therapeutics Inc. stock in 2025Free Stock Selection - jammulinksnews.com
Is it the right time to buy Apogee Therapeutics Inc. stockAchieve consistent double-digit growth rates - jammulinksnews.com
Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - MSN
When is Apogee Therapeutics Inc. stock expected to show significant growthLow Risk Picks With Proven Results - jammulinksnews.com
How volatile is Apogee Therapeutics Inc. stock compared to the marketChart Pattern Updates For Fast Growth - jammulinksnews.com
11 Best Future Stocks to Buy Now - Insider Monkey
Published on: 2025-07-30 23:15:33 - metal.it
Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN
Earnings visualization tools for Apogee Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Multi Factor Analysis Ranks Apogee Therapeutics Inc. as Strong BuyIntraday Trend Analysis for Fast Gains Released - metal.it
Order Book Volume Tilts Bullish on Apogee Therapeutics Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Is Apogee Therapeutics Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - jammulinksnews.com
What makes Apogee Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Elite Traders Group - Newser
What analysts say about Apogee Therapeutics Inc. stockOver 200% growth - PrintWeekIndia
What drives Apogee Therapeutics Inc. stock priceDynamic growth stocks - Autocar Professional
Apogee Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
What makes Apogee Therapeutics Inc. stock attractive to long term investorsDynamic growth stocks - jammulinksnews.com
InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada
Teacher Retirement System of Texas Sells 629 Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) - Defense World
BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN
Will Apogee Therapeutics Inc. stock benefit from interest rate changesTop Gaining Low Risk Assets - Newser
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - MSN
Why Apogee Therapeutics Inc. stock attracts strong analyst attentionLow Risk Stock Strategies - Newser
How Apogee Therapeutics Inc. stock performs during market volatilityStable Growth Stock Picks - Newser
Apogee Therapeutics Inc Azioni (APGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):